Jessica Davis, M.D.

  • Associate Professor of Pathology & Laboratory Medicine, School of Medicine
  • Director, Surgical Pathology


  • B.A., 2005, Carroll College
  • M.D., 2010, Oregon Health & Science University
  • Residency:

    • Chief Resident Clinical Pathology, University of California San Francisco, 2014-2015
    • Chief Resident Anatomic Pathology, University of California San Francisco, 2013-2014
    • Anatomic and Clinical Pathology Resident, University of California San Francisco, 2010-2013
  • Fellowship:

    • Pediatric Pathology Fellow, Seattle Children's Hospital, 2015-2016
    • Surgical Pathology Fellow, University of California San Francisco, 2013-2014
  • Certifications:

    • Pediatric Pathology (American Board of Pathology), 2016
    • Anatomic and Clinical Pathology (American Board of Pathology), 2015

Areas of interest

  • Pediatric soft tissue tumors, with an emphasis in fusion driven tumors.


Selected publications

  • Select publications (full PubMed bibliography link in Additional Information) 
  • Expanding the Spectrum of Pediatric NTRK-rearranged Mesenchymal Tumors. Davis JL, Lockwood CM, Stohr B, Boecking C, Al-Ibraheemi A, DuBois SG, Vargas SO, Black JO, Cox MC, Luquette M, Turpin B, Szabo S, Laetsch TW, Albert CM, Parham DM, Hawkins DS, Rudzinski ER. American Journal of Surgical Pathology. 2019 Apr. PubMed PMID: 30585824.
  • TRK Fusion Cancers in Children: A Clinical Review and Recommendations for Screening. Albert CM*, Davis JL*, Federman N, Casanova M, Laetsch TW. Journal of Clinical Oncology. 2019 Feb 20. PubMed PMID: 30592640. *Authors contributed equally.  
  • EWSR1-NFATC2 Translocation-associated Sarcoma Clinicopathologic Findings in a Rare Aggressive Primary Bone or Soft Tissue Tumor. Wang GY, Thomas DG, Davis JL, Ng T, Patel RM, Harms PW, Betz BL, Schuetze SM, McHugh JB, Horvai AE, Cho SJ, Lucas DR. The American Journal of Surgical Pathology. 2019 Apr 15. PubMed PMID: 30994538.
  •  EWSR1-NFATC2 gene fusion in a soft tissue tumor with epithelioid round cell morphology and abundant stroma: a case report and review of the literature. Cohen JN, Sabnis AJ, Krings G, Cho SJ, Horvai AE, Davis JL. Human Pathology. 2018 Nov. PubMed PMID: 29626598.
  • Pan-Trk Immunohistochemistry Identifies NTRK Rearrangements in Pediatric Mesenchymal Tumors. Rudzinski ER, Lockwood CM, Stohr BA, Vargas SO, Sheridan R, Black JO, Rajaram V, Laetsch TW, Davis JL. American Journal of Surgical Pathology. 2018 Jul. PubMed PMID: 29683818.
  • Infantile NTRK-associated Mesenchymal Tumors. Davis JL, Lockwood CM, Albert CM, Tsuchiya K, Hawkins DS, Rudzinski ER. Pediatric and Developmental Pathology. 2018 Jan-Feb. PubMed PMID: 28683589.
  • Special AT-rich sequence-binding protein 2 (SATB2) expression is sensitive but may not be specific for osteosarcoma as compared with other high-grade primary bone sarcomas. Davis JL, Horvai AE. Histopathology. 2016 Jul. PubMed PMID: 26644288.